Show Summary Details
Page of

Familial hypercholesterolaemia 

Familial hypercholesterolaemia
Familial hypercholesterolaemia
Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 14 October 2019

Familial hypercholesterolaemia 296

Treatment of familial hypercholesteroaemia 298

FH is an inborn error of metabolism that leads to accumulation of LDL-C particles in the blood and premature coronary artery atherosclerosis. In most cases it is caused by defects in the LDL receptor (LDL-R) and a reduced number of functional receptors on the surface of the liver that results in a reduce clearance of LDL-C and thus its accumulation in the plasma. The prevalence of heterozygous FH is 1 in 500 of the population for people of European descent. In heterozygous FH serum LDL-C (and total cholesterol) values are approximately double the usual values. The slower clearance of LDL-C particles also leads to a reduction in LDL particle triglyceride content such that serum total triglyceride values for individuals with FH are usually within the normal range....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.